Skip to main content

Table 1 Patient characteristics

From: HIV patients treated with low-dose prednisolone exhibit lower immune activation than untreated patients

Treatment group Untreated (n = 10) Prednisolone (n = 27) HAART Prednisolone/HAART no treatment, elite controllers
number of patients 10 27 30 31 3
age in years 39 [28.0-50.5] 38 [32.0-47.0] 47 [42.5-61.0] 48 [40.0-58.0] 28, 43, 56*
sex m/f 9 m/1 f 22 m/5 f 24 m/6 f 23 m/8 f 2 m/1 f
time since first HIV diagnosis in years 2 [1.0-4.0] 5 [3.0-13.0] 9 [4.5-16.0] 9 [3.0-14.0] 3, 15, 21*
prednisolone treatment in years n.a. 2.3 [1.2-3.5] n.a. 5 [2.0-5.7]** n.a.
viral load (RNA copies/ml plasma) 1.1 × 105 [0.5-12.2 × 105] 0.8 × 105 [0.2-42.4 × 105] 27 undetectable, others [[46;66;191]] 25 undetectable, others: [[41; 46; 63; 74; 131; 1085]] undetectable
CD4+ counts (cells/μl) 520 [350-670] 550 [460-700] 465[320-655] 390[280-600] 284, 554, 892*